Chronic Kidney Disease Augments Gout Risks

By Jack Cush, MD | 09 April 2019

A population based cohort analysis shows that patients with incident gout and chronic kidney disease (CKD) have far worse outcomes than those without CKD.

A retrospective population-based cohort study of incident gout between 2006-2009 identified those with CKD; defined as a pre-existing diagnosis of chronic kidney disease, chronic renal failure, kidney transplantation, or dialysis at index date.

Among 12,940 incident adult gout patients, 64% with CKD and 36% without CKD, were followed for 55,206 person-years.

Overall, gout patients with CKD (vs those without CKD) had:

Significantly more healthcare utilization; Hospital admissions were at least 3 times higher for Gout+CKD adults < 55 (mean = 0.51 vs 0.13) and approximately 1.5 times higher for adults 55+ (mean = 0.46 vs 0.29) without CKD.
All-cause mortality was higher among those with CKD compared to those without CKD for both age groups (HR< 55 years = 1.65; 95% CI 1.01-2.71; HR55+ years = 1.50; 95% CI 1.37-1.65).

Gout plus CKD constitutes a high risk population that merits focused efforts to better control their gout and optimize comorbidity management.

Disclosures:

The author has no conflicts of interest to disclose related to this subject

Add new comment

If you are a health practitioner, you may Login/Register to comment.

More Like This

Modifiable Risk Factors for Hyperuricemia

By Jack Cush, MD | 05 Sep 2019

Choi and colleagues have shown that four modifiable risk factors (BMI, the DASH diet, alcohol use, and diuretic use) could individually account for a notable proportion of observed hyperuricemia.

Researchers examine modifiable risk factors for hyperuricemia and how this could be prevented through risk factor modification in the general population.

[...]

Opioids Overused in Acute Gout

By MedPage Today | 08 Jul 2019

Opioids were commonly given to patients as a treatment for acute gout attacks, despite the availability of other effective and appropriate therapies, a retrospective study found.

[...]

Allopurinol Fails to Curtail Hypertension

By Jack Cush, MD | 03 Jul 2019

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. A novel trial presented at EULAR 2019 last week assessed whether the use of urate-lowering therapy (ULT) would control hypertension in those at risk; however, results of this trial were largely negative.

Hypertension is one of the many comorbidities that plagues gout patients.

[...]

Allopurinol Fails to Curtail Hypertension

By Jack Cush, MD | 19 Jun 2019

A novel trial presented at EULAR 2019 last week assessed whether the use of urate-lowering therapy (ULT) would control hypertension in those at risk; however, results of this trial were largely negative.

Hypertension is one of the many comorbidities that plagues gout patients.

[...]

Updated 2018 EULAR Recommendations for the Diagnosis of Gout

By Jack Cush, MD | 10 Jun 2019

The first EULAR recommendations for the diagnosis of gout were published in 2006. A task force was formed and following a systematic review, they voted unanimously for changes in all items of the 2006 recommendations.

[...]

You are here